Blueprint Medicines Stock Forward View - Price Action Indicator
| BPMCDelisted Stock | USD 129.46 0.11 0.09% |
Blueprint Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Blueprint Medicines stock prices and determine the direction of Blueprint Medicines Corp's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of Blueprint Medicines' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time the value of rsi of Blueprint Medicines' share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Blueprint Medicines hype-based prediction, you can estimate the value of Blueprint Medicines Corp from the perspective of Blueprint Medicines response to recently generated media hype and the effects of current headlines on its competitors.
Blueprint Medicines after-hype prediction price | USD 129.46 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Blueprint |
Blueprint Medicines Additional Predictive Modules
Most predictive techniques to examine Blueprint price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Blueprint using various technical indicators. When you analyze Blueprint charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check Blueprint Medicines Volatility | Backtest Blueprint Medicines | Information Ratio |
Blueprint Medicines Trading Date Momentum
| On February 14 2026 Blueprint Medicines Corp was traded for 129.46 at the closing time. The top price for the day was 129.55 and the lowest listed price was 129.30 . There was no trading activity during the period 0.0. Lack of trading volume on February 14, 2026 did not affect price variability. The overall trading delta against the current closing price is 0.08% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
Compare Blueprint Medicines to competition
Blueprint Medicines Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Blueprint Medicines stock to make a market-neutral strategy. Peer analysis of Blueprint Medicines could also be used in its relative valuation, which is a method of valuing Blueprint Medicines by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Blueprint Medicines Market Strength Events
Market strength indicators help investors to evaluate how Blueprint Medicines stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Blueprint Medicines shares will generate the highest return on investment. By undertsting and applying Blueprint Medicines stock market strength indicators, traders can identify Blueprint Medicines Corp entry and exit signals to maximize returns.
Blueprint Medicines Risk Indicators
The analysis of Blueprint Medicines' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Blueprint Medicines' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting blueprint stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.86 | |||
| Semi Deviation | 0.6141 | |||
| Standard Deviation | 3.85 | |||
| Variance | 14.85 | |||
| Downside Variance | 1.88 | |||
| Semi Variance | 0.3771 | |||
| Expected Short fall | (2.41) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Blueprint Medicines
The number of cover stories for Blueprint Medicines depends on current market conditions and Blueprint Medicines' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Blueprint Medicines is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Blueprint Medicines' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Blueprint Medicines Short Properties
Blueprint Medicines' future price predictability will typically decrease when Blueprint Medicines' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Blueprint Medicines Corp often depends not only on the future outlook of the potential Blueprint Medicines' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Blueprint Medicines' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 62.9 M | |
| Cash And Short Term Investments | 615.5 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in Blueprint Stock
If you are still planning to invest in Blueprint Medicines Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Blueprint Medicines' history and understand the potential risks before investing.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |